iRhythm Technologies, Inc. (IRTC) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 San Francisco, CA, 미국. 현재 CEO는 Quentin S. Blackford.
IRTC 을(를) 보유 IPO 날짜 2016-10-20, 2,000 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $3.98B.
iRhythm Technologies, Inc. is a digital healthcare company headquartered in San Francisco that specializes in ambulatory electrocardiogram (ECG) monitoring solutions for patients at risk of arrhythmias in the United States. The company's flagship Zio service combines wire-free, patch-based wearable biosensors with a cloud-based analytics platform to enable physicians to continuously monitor patients and diagnose cardiac arrhythmias. Its Zio XT and AT monitors are single-use, wearable patches that record patient heartbeats and ECG data for clinical analysis. iRhythm also collaborates with Verily Life Sciences to develop next-generation atrial fibrillation detection and monitoring products, positioning itself at the intersection of wearable technology and cardiac care.
